GlassScriptPhysician profile
Wesley Robertson
NPI 1154345031
$1,233.93
in general payments reported to CMS, 2019-2025
16 companies · $123 in 2025
The $123 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $104 · 2021: $245 · 2022: $200 · 2023: $185 · 2024: $235 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $280.95 | 2019-2025 | Bexsero, Flulaval Quadrivalent |
| Merck Sharp & Dohme LLC | $263.82 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Cranial Technologies, INC | $133.61 | 2022-2025 | Doc Band |
| Pfizer INC. | $97.52 | 2019-2024 | |
| Kaleo, INC. | $87.56 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $68.98 | 2021-2023 | Vpriv |
| Sanofi Pasteur INC. | $58.23 | 2022-2024 | |
| Ironshore Pharmaceuticals INC. | $54.43 | 2019 | |
| Supernus Pharmaceuticals, INC. | $42.45 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $28.05 | 2024-2025 | Zoryve |
| Astrazeneca Pharmaceuticals LP | $27.34 | 2024 | Flumist Quadrivalent |
| Verrica Pharmaceuticals INC. | $22.49 | 2025 | Ycanth |
| Neos Therapeutics, LP | $20.55 | 2020 | |
| Genzyme Corporation | $19.55 | 2022 | |
| Seqirus USA INC | $14.45 | 2023 | Flucelvax Quadrivalent |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $13.95 | 2025 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.